SCHEMBL24674314

SCHEMBL24674314

CCCc1nc2ccccc2n1-c1ccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3cc(-c4ccccc4)ccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 6/20 0.46
CYP1A2 P05177 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PPARG P37231 2/20 0.41
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
BLM P54132 1/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.39
MAPT P10636 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
KCNH2 Q12809 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10353264 0.97 PDE10A (0.46) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL24674315 0.94 LMNA (0.46) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL24674114 0.94 CYP1A2 (0.47) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL24674406 0.94 CYP1A2 (0.47) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL24674393 0.94 CYP1A2 (0.47) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL10354033 0.94 CYP1A2 (0.47) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL2604843 0.94 CYP1A2 (0.48) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL2604821 0.93 PDE10A (0.48) PDE10ACYP1A2MEN1KMT2ACYP3A4
SCHEMBL23022731 0.92 PDE10A (0.44) PDE10ACYP1A2MEN1KMT2AMAPK1
SCHEMBL24674329 0.92 PDE10A (0.44) PDE10ACYP1A2MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220384734-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220384734-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE MCOLN2, RER1, L1CAM PDE10A 4471/4885CYP1A2 2514/4885MEN1 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.